Natco Pharma shines on getting nod from CDSCO for emergency use of Baricitinib tablets
Natco Pharma shines on getting nod from CDSCO for emergency use of Baricitinib tablets

Natco Pharma shines on getting nod from CDSCO for emergency use of Baricitinib tablets

Apurva Joshi Article rating: 5.0

Natco Pharma Limited has informed the bourses that it has received emergency use approval for Baricitinib tablets in strengths of 1 mg, 2 mg, and 4 mg from Central Drugs Standard Control Organisation (CDSCO), India. Baricitinib, combined with Remdesivir, is used for the treatment of COVID-19 positive patients.

BSE 500 companies with change in promoters holding in March 2021
BSE 500 companies with change in promoters holding in March 2021

BSE 500 companies with change in promoters holding in March 2021

Apurva Joshi Article rating: 4.8

We have listed down the top five companies (listed on BSE 500 index) in which promoters increased their stake along with another set of the top five companies in which promoters have decreased their stake in the quarter ended March 2021 from December 2020 quarter. 

Corinth Group of Switzerland to invest USD 100 million in Morepen Laboratories
Corinth Group of Switzerland to invest USD 100 million in Morepen Laboratories

Corinth Group of Switzerland to invest USD 100 million in Morepen Laboratories

Apurva Joshi Article rating: 4.7

The board of directors of Morepen Laboratories Limited has approved the investment proposed by Corinth Group, a global private investment group, headquartered in Switzerland, to the extent of USD 32.50 million in the parent company, Morepen Laboratories Limited out of a total USD 100 million investment in the promoter group. 

Akash Infra Projects bags order worth Rs 9.36 crore in Mehsana
Akash Infra Projects bags order worth Rs 9.36 crore in Mehsana

Akash Infra Projects bags order worth Rs 9.36 crore in Mehsana

Apurva Joshi Article rating: 4.6

Akash Infra Projects Limited has bagged a work order from the office of the Executive Engineer, Mehsana (R&B) Division worth Rs 9.36 crore for resurfacing of the different road of R&B Sub Division Mehsana (Gujarat) package.

Biocon Biologics and its partner Viatris get EC nod for biosimilar Bevacizumab
Biocon Biologics and its partner Viatris get EC nod for biosimilar Bevacizumab

Biocon Biologics and its partner Viatris get EC nod for biosimilar Bevacizumab

Apurva Joshi Article rating: 5.0

Biocon Limited’s subsidiary Biocon Biologics Ltd has informed the bourses that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc. has received marketing authorisation approval from European Commission (EC), following the positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency. 

Buzzing stock: Orient Refractories trades at all-time high level
Buzzing stock: Orient Refractories trades at all-time high level

Buzzing stock: Orient Refractories trades at all-time high level

Apurva Joshi Article rating: 4.8

In just one year, Orient Refractories Limited has rallied by approximately 147 per cent making an all-time high level of Rs 319.20 from its 52-week low level of Rs 129.50 on BSE. On a YTD basis, this stock has given approximately 27 per cent returns to the investors. 

L&T Construction bags contract to build one of worlds largest oil & gas supply bases in Saudi Arabia
L&T Construction bags contract to build one of worlds largest oil & gas supply bases in Saudi Arabia

L&T Construction bags contract to build one of worlds largest oil & gas supply bases in Saudi Arabia

Apurva Joshi Article rating: 4.7

The buildings & factories business of Larsen & Toubro Construction has secured a significant contract from Oilfields Supply Company in Saudi, owned by Dubai-based Oilfields Supply Center Ltd to design and build one of the world's largest oil & gas supply bases at King Salman Energy Park, Dammam (Kingdom of Saudi Arabia). 

RSS
123468910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR